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Abstract
We report the initial characterization of an N-terminal oligopeptide
‘2A-like’ sequence that is able to function both as a signal sequence
and as a translational recoding element. Owing to this translational
recoding activity, two forms of nascent polypeptide are synthesized: (i)
when 2A-mediated translational recoding has not occurred: the nascent
polypeptide is fused to the 2A-like N-terminal signal sequence and the
fusion translation product is targeted to the exocytic pathway, and,
(ii) a translation product where 2A-mediated translational recoding has
occurred: the 2A-like signal sequence is synthesized as a separate trans-
lation product and, therefore, the nascent (downstream) polypeptide
lacks the 2A-like signal sequence and is localized to the cytoplasm. This
type of dual-functional signal sequence results, therefore, in the parti-
tioning of the translation products between the two sub-cellular sites
and represents a newly described form of dual protein targeting.
Keywords 2A, dual protein targeting, secretory pathway, signal
sequence, translational recoding
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The function of the 2A oligopeptide sequence (18aa)
was first characterized from the positive-stranded RNA
picornavirus Foot-and-Mouth Disease Virus (FMDV).
FMDV 2A was shown to mediate a co-translational
‘cleavage’ between the upstream (capsid proteins) and
downstream (RNA replication proteins) domains of the
FMDV polyprotein (Figure 1A; Refs 1–5). Active 2A
sequences were characterized in the genomes of viruses
from other genera of the picornaviruses, plus ‘2A-like’
sequences found within the genomes of a range of
different RNA viruses and non-LTR retrotransposons
(6–10). These 2A/‘2A-like’ oligopeptide sequences
were shown to mediate a translational ‘recoding’ event
referred-to as ‘ribosome skipping’, ‘stop carry-on’ or
‘stop-go’ translation (11–16). Briefly, when an elongating
ribosome encounters 2A, it ‘skips’ the synthesis of a
specific glycyl-prolyl peptide bond. Although no stop
codon is involved, eukaryotic translation release (ter-
mination) factors 1 and 3 (eRF1/eRF3) are proposed to
release the nascent protein from the ribosome, thereby
forming the C-terminus of 2A (Figure 2). In support
of this model, eRF3 was recently shown to mediate
termination of translation of yeast ribosomes stalled
on polylysine tracts (17), although other recent anal-
yses using re-constituted translation systems did not
support the involvement of eRFs 1 and 3 (18). Our
model of this translational recoding event predicts that
three alternative outcomes arise; having synthesized
sequences upstream of 2A, ribosomes either (i) resume
translation of the downstream sequences, (ii) translation is
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Figure 1: Occurrence of 2A and plas-
mid constructs. A) 2A-mediated transla-
tional recoding serves to separate the capsid
proteins and domains comprising replica-
tive proteins of the FMDV polyprotein. B)
Plasmids encoding the [GFP-2A-GUS] artiﬁ-
cial polyprotein system were used to ana-
lyze 2A recoding activities by the quan-
tiﬁcation of the ‘uncleaved’ [GFP-2A-GUS]
and ‘cleaved’ [GFP-2A] plus GUS transla-
tion products. C) The wild-type SpNLR2A6
sequence and mutated forms were fused to
the N-terminus of GFP for analyses of recod-
ing activities by comparison of the levels
of the [SpNLR2A6WT-GFP] and GFP prod-
ucts. D) Plasmid pJN1 was used as a con-
trol for the sub-cellular localisation stud-
ies: the T2A sequence ‘cleaves’ to produce
[mCherry-T2A] and GFP. Neither protein has
a signal sequence and both colocalize within
the cytoplasm. E) SpNLR2A sequences were
fused to the N-terminus of mCherry: the sig-
nal sequence activities were determined by
the extent of colocalization with (cytoplas-
mic) GFP.
terminated at that point, or, (iii) that no translational
recoding occurs: the glycyl-prolyl peptide bond is formed
and the protein is synthesized in the normal manner. The
ratio of these translation products is dependent upon the
specific 2A-like sequence in question – amodel supported
by the observations from many other laboratories that
have used 2A for biomedical or biotechnological protein
co-expression applications (19).
Our analyses of this recoding event were based upon the
creation of an artificial polyprotein system comprising
green fluorescent protein (GFP; stop codon removed)
linked, via the 2A-like sequence being analysed, to
β-glucuronidase (GUS; initiation codon removed) to cre-
ate a single open reading frame (ORF; [GFP-2A-GUS];
Figure 1B). The translation products from these exper-
iments are (i) the [GFP-2A-GUS] fusion protein, (ii)
[GFP-2A] – 2A remains as a C-terminal extension of
the upstream protein, and (iii) GUS. For the most active
2A/2A-like sequences, the major products (90–99%) are
[GFP-2A] and GUS. The full-length translation product
[GFP-2A-GUS] is, however, also observed – particularly
for 2A/2A-like sequences with lower recoding activities
(8,9). In some cases the biological function of 2A lies in
very high – essentially complete – ‘cleavage’ to generate
the individual, discrete, translation products, while in other
cases the biological function of 2A appears to be the gener-
ation of a mixture of both ‘cleaved’ (translation ‘recoded’)
and ‘uncleaved’ forms (translation not recoded) – the
proportions of which varies among different 2A-like
sequences. For simplicity, the terms ‘cleaved’/‘uncleaved’
will be used below.
In all the cases outlined above, the 2A/2A-like sequences
are present within virus or ‘virus-like’ – non-LTR (long
terminal repeat) retrotransposon genomes and encoded
at internal sites within proteins/polyproteins. A motif
(−D[V/I]ExNPGP−) is conserved at the C-terminus
of all 2A/2A-like sequences: this motif must, how-
ever, be accompanied by an appropriate, but much
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Figure 2: Model of 2A-mediated translational ‘recoding’. When the nascent peptide upstream of 2A is emerging from the
ribosome, 2A is positioned in the ribosome exit tunnel (step 1). The nascent peptide-2A and glycyl-tRNA is translocated from the A- to
P-site and prolyl-tRNA enters the A-site (step 2). The nascent 2A peptide interacts with the exit tunnel of the ribosome such that the
C-terminal portion (−ESNPG-) is sterically constrained within the peptidyl-transferase centre (PTC) of the ribosome. Nucleophilic attack
of the ester linkage between 2A and tRNAgly by prolyl-tRNA in the A-site is inhibited – effectively stalling, or pausing, translation. The
failure to form a new peptide bond leads to dissociation of prolyl-tRNA from the A-site of the ribosome (step 3), required for entry of
release factors into the A-site (step 4). We have shown that this block is relieved by the action of translation release factors eRF1 and
eRF3, hydrolyzing the ester linkage (step 5) and releasing the nascent protein (step 6). eRF1 leaves the complex, eRF3 being involved
in this process (step 6). Two, mutually exclusive, outcomes may then arise: (i) translation terminates at the C-terminus of 2A, or, (ii)
prolyl-tRNA (re)enters the A-site (step 7), is translocated by eukaryotic elongation factor 2 (eEF2) from the A- to the P-site (step 8),
allowing the next amino-acyl tRNA to enter the A-site to permit the synthesis of the sequences downstream of 2A (step 9).
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less conserved, upstream context for the 2A/2A-like
sequence to function as a translational recoding element.
Probing databases with this C-terminal motif identified
numerous 2A-like sequences in non-LTR retrotrans-
posons within the genome of Trypanosoma cruzi (and
other trypanosome species, Ref 7) and, latterly, in a
range of other species from different families/genera
(9). For one of these species, the purple sea urchin
Strongylocentrotus purpuratus, 2A-like sequences were
also identified in genes involved in the innate immune sys-
tem. S. purpuratus has a large repertoire of immune-related
genes that recognize pathogen-associated molecular pat-
terns (20,21). The NOD-like receptor proteins (NLR;
nucleotide-binding domain and leucine-rich repeat) gene
family encode proteins with a common architecture: an
N-terminal effector-binding (DEATH) domain, a NACHT
nucleotide-binding domain and a C-terminal domain
comprising leucine-rich repeats. These NLR proteins
localize within the cytoplasm whereas a similar family
of pattern recognition receptors, the toll-like receptors,
possess transmembrane domains and localize to the
plasma or endosomal membranes (reviewed in 22–26).
Bioinformatic analyses showed that ∼35% (85/241)
of these S. purpuratus NLR proteins contain 2A-like
sequences: surprisingly not as internal features, but either
at their N-termini, or, within the N-terminal region.
The S. purpuratus NLR N-terminal 2A-like sequences
(SpNLR2As) we have identified are shown in Table 1.
Furthermore, bioinformatic analyses also showed a high
proportion of these SpNLR2As were predicted to func-
tion as co-translational signal sequences. Two questions
arose immediately; (i) are these 2A-like sequences active
in translational recoding? and (ii) if they remain fused
to the downstream sequences, could they indeed func-
tion as a co-translational signal sequence? Since these
SpNLR2As were N-terminal features, we adopted the
same strategy of using an artificial polyprotein reporter
system, but adapted such that we could use the same
type of construct as the basis for the analyses of both the
recoding activity and the effect of these SpNLR2As on
protein sub-cellular localization. Since the function of
signal sequences is known to be retained across diverse
eukaryotic cell-types (27), for pragmatic reasons we stud-
ied these potential echinoderm signal sequences using
mammalian cells. To extend the scope of any potential
biotechnological uses of these sequences we also examined
‘cleavage’ and sub-cellular protein targeting within
plant cells.
Our data show that this N-terminal form of 2A possesses
both translational recoding and signal sequence activi-
ties in mammalian and plant cells. We propose that these
translational recoding signal sequences represent a newly
characterized form of dual protein targeting: in the pro-
portion of cases where a peptide bond is formed between
the SpNLR2A signal sequence and the downstream pro-
tein (translation not recoded), then the fusion protein
is targeted to the exocytic pathway. Where the peptide
bond is not formed (‘skipped’) by the translational recod-
ing activity of the SpNLR2A, then the signal sequence
and the downstream protein emerge from the ribosome as
individual, discrete, translation products. While we have
not investigated the fate of the oligopeptide SpNLR2A
signal sequence [interaction with signal recognition par-
ticle (SRP) or degradation?], we show that lacking an
N-terminal signal sequence the downstream protein local-
izes to the cytoplasm – taken together, a novel form of dual
protein targeting.
Results
Bioinformatic analyses
Sequence databases were probed with the conserved
–D(V/I)ExNPGP- motif using BLASTp (initially at the
Baylor College of Medicine, latterly at NCBI). S. purpu-
ratus sequences encoding 2A-like sequences could be
divided into two main categories: non-LTR retrotrans-
posons (9) and NLR proteins. Probing the NCBI database
for NLR sequences (using the NACHT domain from
NP_001120727.1 as a probe) shows that the early figure for
NLR proteins encoded within the S. purpuratus genome
(203 NLR proteins; Ref 20) was reduced to 87 entries
in NCBI, 14 of which possess a 26aa 2A-like sequence
at their N-termini (Table 1). These sequences were then
analysed using SignalP 4.1 (28) for signal peptide pre-
diction: the D-cutoff values are shown in Table 1. Of
the 14 such sequences analysed, 12 were predicted to
function as co-translational signal sequences (D-cutoff
values≥ 0.45). The algorithm also predicted a signal pep-
tidase complex cleavage site towards the C-terminus of
the SpNLR2A6WT (−VET↓NPG-) and SpNLR2A6P3A
(−VET↓NAG-) sequences.
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Table 1: S. purpuratus N-terminal NLR 2A-like sequences: wild-type sequences and site-directed mutants
Naturally-occurring S. purpuratus
NLR N-terminal 2A-like sequencesS. purpuratus
NLR proteins:
database accession no.
SignalP 4.1
D-value 26 25 24 23 22 21 20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1
Recoding
activity in
[GFP-2A-GUS]
XP_785721.3
XP_797335.3 +
XP_003723709.1 (SpNLR2A6) +++++
XP_001184399.2
XP_003729541.1
XP_003724839.1
XP_800245.3 +
XP_003730118.1
XP_003728571.1 +
XP_003729593.1
XP_003723697.1
XP_003727629.1
XP_003730320.1
XP_003724840.1
SpNLR2A6 (XP_003723709.1)
site-directed mutants
S. purpuratus
NLR proteins:
database
accession no.
Signal
P 4.1
D-value 26 25 24 23 22 21 20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1
Recoding
activity in
[GFP-2A-GUS]
SpNLR2A6WT 0.542 +++++
SpNLR2A6 P3A 0.475 −
SpNLR2A6D25A 0.593 +++++
SpNLR2A6D25A,P3A 0.522 −
SpNLR2A6L21V 0.512 +++++
SpNLR2A6L21V,P3A 0.450 −
SpNLR2A6L21G 0.451 +++++
SpNLR2A6L21G, P3A 0.400 −
SpNLR2A6L21D 0.372 +++
SpNLR2A6L21D, P3A 0.325 −
SpNLR2A6L21A 0.495 +++++
SpNLR2A6L21A,P3A 0.435 −
SpNLR2A6L16V 0.491 +++++
SpNLR2A6L16G 0.391 +++++
SpNLR2A6L16G, P3A 0.541 −
SpNLR2A6L16D 0.322 +++++
SpNLR2A6L16D, P3A 0.452 −
SpNLR2A6L16A 0.457 +++++
+++++
+++++
SpNLR2A6L16A,P3A 0.584 −
SpNLR2A6L16M 0.473
SpNLR2A6L16M,P3A 0.418 −
SpNLR2A6L14G 0.406 +
SpNLR2A6L14D 0.347 +
SpNLR2A6L14D,P3A 0.387 −
SpNLR2A6L13V 0.488 ++
SpNLR2A6L13V,P3A 0.608 −
SpNLR2A6L13A 0.472 +
SpNLR2A6L13A, P3A 0.596 −
SpNLR2A6M12V 0.528
SpNLR2A6M12V,P3A 0.596 −
SpNLR2A6R11A 0.599 ++
SpNLR2A6R11A,P3A 0.627 −
0.557 M D G F C L L Y L L M I L L V R S G D V E T N P G P (NT)
0.557 M D G L C L L Y L L L I L L M R S G D V E T N P G P
0.542 M D G F C L L Y L L L I L L M R S G D V E T N P G P
0.542 M D G F C L L Y L L L I L L M R S G D V E T N P G P (NT)
0.542 M D G F C L L Y L L L I L L M R S G D V E T N P G P (NT)
0.534 M V G F C L L Y L I M I L L M R S G D V E T N P G P (NT)
0.528 M D G F C L L Y L L L I L L V R S G D V E T N P G P
0.500 M A G F C L L Y L I M I L L M R S G D V E T N P G P (NT)
0.473 M D G F C L L Y L L M I L L M R S G D V E T N P G P
0.473 M D G F C L L Y L L M I L L M R S G D V E T N P G P (NT)
0.473 M D G F C L L Y L L M I L L M R S G D V E T N P G P (NT)
0.450 M D A F C L L Y L I M I L L M R S G D V E T N P G P (NT)
0.444 M G G F C H L Y L L M I L L M R S G D V E T N P G P (NT)
0.438 M D G F C L L Y L I M I L L M R S G D V E T N P G P (NT)
M D G F C L L Y L L L I L L M R S G D V E T N P G P
M A G F C L L Y L L L I L L M R S G D V E T N P G P
M D G F C L L Y L L G I L L M R S G D V E T N P G P
M D G F C L L Y L L L I L L V R S G D V E T N P G P
M D G F C L L Y L L L I L L M R S G D V E T N A G P
M A G F C L L Y L L L I L L M R S G D V E T N A G P
M D G F C V L Y L L L I L L M R S G D V E T N P G P
M D G F C V L Y L L L I L L M R S G D V E T N A G P
M D G F C G L Y L L L I L L M R S G D V E T N P G P
M D G F C G L Y L L L I L L M R S G D V E T N A G P
M D G F C D L Y L L L I L L M R S G D V E T N P G P
M D G F C D L Y L L L I L L M R S G D V E T N A G P
M D G F C A L Y L L L I L L M R S G D V E T N P G P
M D G F C A L Y L L L I L L M R S G D V E T N A G P
M D G F C L L Y L L V I L L M R S G D V E T N P G P
M D G F C L L Y L L G I L L M R S G D V E T N A G P
M D G F C L L Y L L D I L L M R S G D V E T N P G P
M D G F C L L Y L L D I L L M R S G D V E T N A G P
M D G F C L L Y L L A I L L M R S G D V E T N P G P
M D G F C L L Y L L A I L L M R S G D V E T N A G P
M D G F C L L Y L L M I L L M R S G D V E T N P G P
M D G F C L L Y L L M I L L M R S G D V E T N A G P
M D G F C L L Y L L L I G L M R S G D V E T N P G P
M D G F C L L Y L L L I D L M R S G D V E T N P G P
M D G F C L L Y L L L I D L M R S G D V E T N A G P
M D G F C L L Y L L L I L V M R S G D V E T N P G P
M D G F C L L Y L L L I L V M R S G D V E T N A G P
M D G F C L L Y L L L I L A M R S G D V E T N P G P
M D G F C L L Y L L L I L A M R S G D V E T N A G P
M D G F C L L Y L L L I L L V R S G D V E T N A G P
M D G F C L L Y L L L I L L M A S G D V E T N P G P
M D G F C L L Y L L L I L L M A S G D V E T N A G P
The relative translational recoding abilities (where tested) and the Signal-P D-values are reported for each NLR protein sequence. Residues are colour-coded as acidic (green) and basic (light
blue) together with residues within the conserved C-terminal motif (grey). Residues are numbered following the accepted nomenclature for proteinase ‘cleavage’ by incrementing the numbering
in the N-terminal direction of the cleaved peptide bond (P2, P3, P4, etc.). Translational recoding activity was ablated by creating a second site mutation (P3A) within the conserved C-terminal
motif. NCBI accession numbers are listed for the wild-type sequences.
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Functional assays
Since co-translational signal sequences are known to func-
tion across kingdoms (27), we chose to analyze both the
translational recoding and protein targeting functions of
these SpNLR2As in an immortalized cell type (mammalian
HeLa) readily available to us, as no immortalized echino-
derm cell-lines were available. The tandem CMV and T7
promoters in the pCDNA plasmid backbone used for DNA
constructions facilitated analyses by both programming
a coupled in vitro transcription/translation system (T7
promoter), or, be used to direct transcription following
transfection of mammalian cells (CMV promoter) to
study cellular expression and protein sub-cellular localiza-
tion (Figure 1C). Our control construct (pJN1; Figure 1D)
comprised a single ORF encoding [mCherry-T2A-GFP] to
which the SpNLR2A sequences were added as N-terminal
fusions. The highly efficient T2A sequence ‘cleaves’ GFP
as a discrete product, providing an internal control for
the cell expression studies since, in the absence of a sig-
nal sequence, both the mCherry and GFP localize to
the cytoplasm. The inclusion of a translational recoding
signal sequence that does not ‘cleave’ and remains fused
at the N-terminus would alter the sub-cellular local-
ization of the translation products produced from the
pSpNLR2A6WT-mCherry-T2A-GFP plasmid constructs
(Figure 1E) such that the [SpNLR2A6WT-mCherry-T2A]
would now enter the exocytic pathway while the GFP
would localize to the cytoplasm (29). ‘Cleavage’ of the
signal sequence would produce mCherry and GFP colo-
calization in the cytoplasm. For expression within plant
cells (Nicotiana benthamiana), the inserts were transferred
to a Tobacco mosaic virus (TMV)-based over-expression
vector to produce intense fluorescence and facilitate clear
determination of sub-cellular localization (30).
We chose to base our analyses upon the SpNLR2A
sequence from the database entry XP_003723709.1 (des-
ignated SpNLR2A6) which scored highly in the SignalP4.1
analyses (Table 1). As a control for both translational
recoding and sub-cellular localization experiments, we
created a single point mutant (P3A) which we have
previously shown to ablate recoding activity (6).
Functional assay: translational recoding activities
To analyze the translation recoding activities of the
SpNLR2A6 sequences, plasmid constructs were used
to program cell-free coupled transcription/translation
systems. Such systems lack any ER-derived membranes,
so only show de novo protein synthesis without any
‘processing’ of signal peptides. The expected translation
products from the various SpNLR2A6 constructs were
the ‘uncleaved’ form [SpNLR2A6P3A-GFP] (29.9 kDa)
together with the GFP ‘cleavage’ product (∼27 kDa)
(Figures 1C and 3). The recoding activity of the wild-type
SpNLR2A6 sequence was high (qualitatively estimated
at ∼80%), while the control mutant, SpNLR2A6P3A, was
completely inactive for translational recoding. Mutations
within the sequence (R11A, L13V, L13A, L14G, L14D)
proximal to the conserved –D(V/I)ExNPGP- motif,
but within a short tract of long side-chain hydrophobic
residues present within many 2A-like sequences (8),
substantially reduced the recoding activity. Additional
mutations more distal (D25A, L21V, L21D) reduced
recoding activity to a lesser extent. Other mutations
(L21G, L21A, L16V, L16G and L16D) had little, or no,
effect on recoding (Figure 3). The two naturally-occurring
sequences that varied from SpNLR2A6 (L16M, M12V)
were as active as the wild-type SpNLR2A6 sequence.
These data are consistent with our previous analyses of
site-directed mutants (8), but suggest that within the range
of naturally-occurring SpNLR2A sequences (Table 1) a
range of translation recoding (and, therefore, a range in
the partitioning of translation products between different
sub-cellular sites) would be observed.
Protein localization: expression in mammalian cells
Transfection of HeLa cells with the reporter plasmid
encoding the wild-type SpNLR2A6 signal sequence
(pSpNLR2A6WT-mCherry-T2A-GFP, Figure 1D),
highly active in translational recoding and, there-
fore, ‘cleavage’ of the signal sequence, showed both
the major cleavage products [mCherry-T2A] and
GFP to localize to the cytoplasm (Figure 4A, upper
panel). Transfection of HeLa cells with the plasmid
encoding the mutant SpNLR2A6 signal sequence
(pSpNLR2A6P3A-mCherry-T2A-GFP), inactive for trans-
lational recoding and, therefore, the pSpNLR2A6P3A signal
sequence remaining fused to mCherry, showed that while
the GFP cleavage product localized to the cytoplasm, the
[SpNLR2A6P3A-mCherry-T2A] now localized primarily to
the Golgi apparatus (Figure 4A, middle panel), confirmed
by brefeldin A treatment (BFA; Figure 4A, lower panel).
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Figure 3: In vitro coupled transcription/translation analyses. SDS–PAGE analyses of the wild-type sequence is shown,
together with the residue numbering system. Coupled transcription/translation systems were programmed with plasmid DNA encoding
the point mutations as indicated. The distribution of radiolabel was visualized by autoradiography. Note: All doubly-mutated sequences
bearing the P3A mutation were recoding inactive (data not shown).
Figure 4: In vivo expression. Mammalian (HeLa) cells were transfected with plasmid DNA as indicated and stained with DAPI
(scale bar= 15 μM). Both translation products from pSpNLR2A6WT-mCherry-T2A-GFP localized to the cytoplasm (Panel A: upper
images), whereas in the case of cells transfected with plasmid pSpNLR2A6P3A-mCherry-T2A-GFP, ﬂuorescence from GFP was localized
to the cytoplasm while ﬂuorescence from mCherry predominantly localized to the Golgi apparatus (Panel A: centre images). Brefeldin
A treatment of cells transfected with plasmid pSpNLR2A6P3A-mCherry-T2A-GFP collapsed the mCherry ﬂuorescence back onto the
endoplasmic reticulum (Panel A: lower images). Analyses of all of the doubly-mutated forms (all comprising the P3A mutation) showed
the same pattern of protein localization as for pSpNLR2A6P3A-mCherry-T2A-GFP (Panel B).
BFA inhibits the activity of the guanine exchange factor
GBF1, thereby inhibiting protein transport from the ER to
the Golgi apparatus: on-going retrograde transport ‘col-
lapses’ the Golgi onto the ER – relocalizing Golgi proteins
to the ER. To perform similar protein sub-cellular localiza-
tion analyses upon the range of site-directed mutant forms
we created (Figure 3), we needed to introduce a second
site mutation (P3A) to ablate the translational recoding
activity of the various SpNLR2A6 mutants (Table 1).
Analyses of these double mutant forms showed that the
mutations upstream of P3A had no discernible effect upon
the distribution of mCherry fluorescence within the cell:
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while some of the mutations we created did affect the
translational recoding activity, these mutations did not
appear to affect the interaction with SRP (examples shown
in Figure 4B).
Transfected cells showed comparable protein expression
levels between pJN1 (encoding [mCherry-T2A-GFP]), and
pSpNLR2A6 constructs (SpNLR2A6-mCherry-T2A-GFP)
encoding either SpNLR2A6WT or SpNLR2A6P3A (Figure 5,
Panel A). Quantitative western blot analyses of the propor-
tions of these translation products which either remained
cell-associated, or, was secreted into the media was per-
formed. For both types of analyses of transfected cells, an
anti-β-tubulin antibody was used to detect the cytoplas-
mic protein β-tubulin as a control. Since this protein is
released into the media by cell lysis, the degree of pro-
tein ‘cross-contamination’ between cells and the tissue cul-
ture media was performed using both anti-β-tubulin and
anti-mCherryFP antibodies. In this manner the mCher-
ryFP within the media (present due to both cell lysis plus
any secretion) could be directly compared with β-tubulin
within the media (present due to cell lysis alone).
Our data showed that in the case of cells transfected
with plasmid pSpNLR2A6P3A-mCherry-T2A-GFP, sig-
nificantly more mCherry was detected in the media than
that observed for cells transfected with pSpNLR2A6WT-
mCherry-T2A-GFP (Figure 5, Panel B). The results
from the quantitative western blot analyses showed
that ∼56% of [SpNLR2A6P3A-mCherry-T2A] was cell-
associated, with ∼44% present in the media. In the
case of the wild-type SpNLR2A6 sequence, ∼85% of
[SpNLR2A6WT-mCherry-T2A] was cell-associated,
with ∼15% present in the media (Figure 5, Panel B).
Interestingly, these data are consistent with the level
of SpNLR2A6WT recoding activity which produced
approximately the same proportion of in vitro trans-
lation products with, and without, the N-terminal
SpNLR2A6WT signal sequence (Figure 3). In the case
of [SpNLR2A6P3A-mCherry-T2A], a proportion of this
product will naturally be cell-associated as it traffics
through the exocytic pathway. An alternative method of
analyzing these transfected cells confirmed these data.
Live-cell imaging using an IncuCyte Zoom microscope
(Essen Bioscience) showed the mCherryFP signal to be
higher – by the same proportion – for cells transfected
Figure 5: Analyses of cellular/secreted protein.
A) Western blots from transfected cell lysates show-
ing comparable protein expression levels between pJN1
(encoding [mCherry-T2A-GFP]), and pSpNLR2A6 con-
structs (SpNLR2A6WT-mCherry-T2A-GFP) encoding either
SpNLR2A6WT or SpNLR2A6P3A. The negative control comprised
non-transfected HeLa cells. Cells were harvested at 30 h
post-transfection. The cytoskeletal protein β-tubulin was used as
a further positive control. B) Quantitative western blot analyses
were performed on cells transfected with pSpNLR2A6WT (lanes
a, b) or pSpNLR2A6P3A (lanes c, d). Using Image Studio Lite soft-
ware, regions of the gel were selected for analyses (boxed areas)
and the secondary antibody ﬂuorescent intensity determined
for the anti-β-tubulin loading controls for cells transfected with
pSpNLR2A6WT (lane a, box 1= 12 200) and pSpNLR2A6P3A
(lane c, box 3= 15 900). Normalizing the mCherryFP ﬂuores-
cence data using the β-tubulin loading controls (lane a, box 1
and lane c, box 3) the SpNLR2A6P3A cell-associated mCherryFP
intensity (lane c, box 5= 1260), becomes 967. In both cases
no tubulin was detected in the protein prepared from cell
media by (lanes b, d). For cells transfected with pSpNLR2A6WT,
the proportion of mCherryFP that was cell-associated (lane
a, box 4= 1240) was 85%, while that in the medium (lane
b, box 9= 226) was 15%. In the case of cells transfected
with pSpNLR2A6P3A, the proportion of mCherryFP that was
cell-associated (lane c, box 5= 1260: normalised to 967 using
the β-tubulin loading control) was 56%, while the proportion of
mCherryFP in the medium (lane d, box 10= 751) was 44% – a
much higher proportion in the medium.
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with pSpNLR2A6P3A than for cells transfected with
pSpNLR2A6WT. Here, the cell-associated mCherryFP
fluorescence intensity was normalised against the (cyto-
plasmically localized) GFP signal. Again, the data are
consistent with the secretion of mCherryFP from cells: out
of the focal plane and into the media (data not shown).
Soluble transfected-cell proteins were analyzed by SDS–
PAGE and subsequent mass-spectrometry (Figure 6). Pro-
teins between 25 and 30 kDa were subjected to MS/MS
analyses and the data showed that a substantial signal arose
from mCherry where the N-terminal sequence data indi-
cated that the SpNLR2A6P3A (recoding inactive) signal
peptide had been ‘cleaved’ away at the site predicted by the
SignalP 4.1 algorithm (−VET↓NAG-): presumably by the
signal peptidase complex.
Protein localization: expression in plant cells
It should be noted that our analyses of the echino-
derm sequences were performed using mammalian cells:
for potential biotechnological purposes, we tested the
activities of the SpNLR2A6 sequence in plants. When
[SpNLR2A6WT-mCherry-T2A-GFP] was expressed in
N. benthamiana leaf epidermal cells, mCherry fluores-
cence colocalized completely with unfused GFP in the
peripheral cytoplasm and nucleoplasm (Figure 7A,C),
as is typical of free fluorescent proteins in plants
(31). When [SpNLR2A6P3A-mCherry-T2A-GFP] was
over-expressed, the resulting mCherry and GFP flu-
orescence were clearly separated. GFP showed a
nucleo-cytoplasmic distribution with nucleolar exclusion
as for [SpNLR2A6WT-mCherry-T2A-GFP]. By contrast,
mCherry fluorescence weakly labelled the nuclear enve-
lope which is continuous with the ER, indicating that
the protein was directed into the lumen of endomem-
branes by the SpNLR2A6P3A leader (Figure 7B,D).
Additionally, in merged mCherry and GFP images,
a fluorescent apoplastic halo of mCherry was visible
surrounding the GFP-labelled cytoplasm. This distri-
bution is typical of secreted proteins (29,32,33). A very
faint mCherry fluorescence was also detectable in the
central vacuole; this is sometimes observed with flu-
orescent proteins directed into the secretory pathway
(34,35) and may be caused by the T2A peptide remaining
attached to the C-terminus of mCherry, as C-terminal
FMDV 2A can act as a vacuolar mis-targeting signal in
N. benthamiana epidermis (35). To further verify these
observations, we colocalized SpNLR2a6WT-mCherry and
SpNLR2A6P3A-mCherry constructs with GFP targeted
to the ER lumen (32) and to the plasma membrane
(31). The ER marker confirmed the observation that
SpNLR2A6P3A-mCherry, but not SpNLR2A6WT-mCherry,
colocalized with the nuclear envelope (Figure 7E,F). In
cells with high expression levels, SpNLR2A6P3A-mCherry,
but not SpNLR2A6WT-mCherry also colocalized with the
tubular ER network (Figure 7G,H). Furthermore, using
GFP-labelled plasma membrane as a marker for the cell
boundary it was apparent that SpNLR2A6P3A-mCherry,
but not SpNLR2A6WT-mCherry, was present in the
intercellular cell wall space (Figure 7I,J). Thus, the
SpNLR2A6WT sequence mediates cleavage in plants like
T2A and FMDV 2A (36), whereas the cleavage-deficient
SpNLR2A6P3A acted as a signal sequence leading to
secretion of [mCherry–T2A] into the cell wall.
Discussion
Dual protein targeting encompasses a range of different
mechanismswhereby the translation products arising from
a single gene may be distributed across several subcellular
sites (reviewed in 37, 38). Many of these effects involve
post-translational mechanisms. Proteins may contain
a single, ambiguous, signal that may be recognized by
more than one type of receptor, each located at a different
sub-cellular site: in plants, the majority of dual-targeted
proteins partition between mitochondria and chloro-
plasts. Over 100 such dual-targeted proteins are currently
known (39–41). Proteins may contain multiple, different,
targeting signals whose functions may be controlled by
accessibility to, and relative affinities for, their respective
receptors. Signal sequences may be masked by a range
of different mechanisms, or, post-translation modifica-
tions (including proteolysis) may inactivate or completely
remove such signals. Mechanisms of dual protein targeting
involving co-translational signal sequences are, however,
less common: alternative splicing may produce a mixture
of mRNAs – a proportion encoding a signal sequence, a
proportion not. In the case of an mRNA that does encode
a signal sequence, alternative sites of the initiation of
translation produces a mixture of translation products
with, and without, signal sequences.
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Our data reveals a novel mechanism of dual protein local-
ization by dual-functional signal sequences; (i) active in
translational recoding and (ii) capable of targeting to the
exocytic pathway, most likely via an SRP-dependent pro-
cess. Our data also shows that relative partitioning of the
translation products between the cytoplasm and secre-
tion can be determined by the nature of the translational
recoding sequence itself – controlling the levels of transla-
tional recoding. It should be noted that the reporter genes
we chose for our analyses of SpNLR2A6 do not comprise
any other form of localization signal. In natural biologi-
cal contexts, however, proteins downstream of such signal
sequences may well do so.We have postulated that the out-
come of translational recodingmay be regulated by cellular
(translational) stress: that the regulation of the activity of
elongation factor 2 (eEF2, proposed to be a key factor in the
translation of sequences downstream of 2A) is regulated
by eEF2 kinase – which, in turn, is regulated by cellular
stress pathways (10,15). Transposing this model onto the
recoding-type signal sequences reported here, the model
would predict that as a response to cellular stress pathways
downregulating eEF2 activity, increased stress would lead
to decreased synthesis of sequences downstream of such
a signal sequence. Alternatively, during evolution, single
point mutation of this sequence could regulate the propor-
tions of translation products localizing to the cytoplasm or
be secreted from the cell. The manifold biological implica-
tions of this system remain to be determined.
With regards the biotechnological utilities which may
arise from these observations, the ability to both localize a
protein to the cytoplasm and to secrete the same product
from the cell has obvious potential applications. 2A has
been shown to work in all eukaryotic systems tested to
date (19) and the mechanism of protein translocation
across the ER membrane is generally conserved across
kingdoms (27). With regards our observations using
plant cells, 2A peptides have been shown to mediate
translational recoding in plants (42), thus the respec-
tive functionalities of SpNLR2A6P3A and SpNLR2A6WT
in plant cells was not surprising. Since the reporter
constructs were delivered by a viral vector (in case of
SpNLR2A6-mCherry-T2A-GFP dual reporters) and
agrobacteria (in all cases) into plant cells, i.e. in the context
of pathogen infections, it might similarly be expected
that at least some of the [SpNLR2A6WT-mCherry] was
secreted. Indeed, very faint extracellular mCherry flu-
orescence was observed with this construct (Figure 7I)
although the majority of mCherry clearly stayed in the
cytoplasm due to translational recoding by SpNLR2A6WT.
It is fruitless to speculate as to the evolutionary origins or
relationships between cellular (signal sequences/non-LTR
retrotransposons) and virus 2A/2A-like sequences: given
the shortness of these 2A/2A-like sequences a polyphyletic
origin is entirely feasible (even probable), but it is notewor-
thy thatwith a relativelymodest number of pointmutations
a ‘classical’ signal sequence could acquire an additional
translational recoding capacity – or vice versa!
Materials and Methods
Plasmid constructs
Plasmids created for in vitro coupled transcription/translation analyses
and mammalian cell transfection were based upon a pCDNA3.1 vec-
tor backbone, encoding tandem CMV and T7 promoters immediately
upstream of the inserts described below. Sites of SpNLR2A6 mutations
described below were designated as per the numbering scheme shown in
Figure 6: Mass spectrometry. Pie-chart summarizing the relative abundance of each of the SpNLR2A6P3A-derived tryptic peptide
species: pink, red etc. shaded areas corresponding to signalase cleaved peptides (B–F), light/dark blue shaded areas corresponding to
non-(signalase) cleaved peptides (G–H) (Panel A). Chart areas correspond to the relative abundance of the individual MS traces obtained
from a Coomassie-stained protein band corresponding to ∼30 kDa (Panels B–H). B–H) show the extracted ion chromatograms (XIC)
displaying the extracted peak(s) of the mass to charge ratio (m/z) of the peptide of interest. Plots are time (x-axis) against intensity
(y-axis). The arrows identify the peak(s) corresponding speciﬁc peptide sequence shown. Tryptic peptides detected with N-termini
corresponding to the predicted signalase cleavage site are shown (B–F), together with those uncleaved (by signalase) peptides (G–H).
Amino acids in bold correspond to C-terminal residues from the SpNLR2A6P3A peptide, the downstream residues correspond to in-frame
N-terminal residues from mCherry. Underlined residues have been post-translationally modiﬁed: oxidated (Panels D, F) or deaminated
(Panel C).
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Table 1. All constructs described below were verified by automated DNA
sequencing.
Plasmid pSpNLR2A6WT encodes SpNLR2A6WT fused to GFP
(Figure 1C). The plasmid was constructed by PCR amplification of GFP
using a forward primer JN1for (5′-GCTAGCTCTAGAACCATGGAT
GGATT CTGTCTTCTCTATCTGCTCCTGATCCTCTTGATGAGATC
TGGTGACGTTGAAACCAATCCCGGGCCCATCGTGTCCAAAGGG
GAA-3′). This primer encoded NheI/XbaI RE sites (underlined),
SpNLR2A6, ApaI RE site (underlined: introduced to facilitate subsequent
SpNLR2A mutagenesis) plus the sequence encoding the N-terminal six
residues of GFP (omitting the initiating AUG).The reverse primer JN1rev
(5′-CCCGGGATTTTCCTCCAC-3′) encoded the C-terminal 6aa of
Thosea asigna virus 2A (T2A) comprising a SmaI RE site (underlined).
The PCR product was restricted with NheI and SmaI and ligated into
pJN1, similarly restricted.
Plasmid pSpNLR2A6P3A encodes a mutated – recoding inactive – form
of SpNLR2A6 (SpNLR2A6P3A) fused toGFP.Theplasmidwas constructed
by PCR amplification of GFP using the forward primer JN2for (5′-GCTA
GCTCTAGAACCATGGATGGATTCTGTCTTCTCTATCTGCTCCTGA
TCCTCTTGATGAGATCTGGTGACGTTGA AACCAATGCCGGGCC
CGGGCCCATCGTGTCCAAAGGGGAA-3′), identical to JN1for –
other than the single point mutation within the SpNLR2A6 (bold, italic,
type face), and the reverse primer JN1rev. Cloning into pJN1 was as
described above.
Plasmid pJN1 encodes an [mCherry-T2A-GFP] self-processing
polyprotein (Figure 1D). Here, mCherry is linked in a single ORF,
via a highly active 2A-like sequence from T2A, to GFP (6). Essen-
tially all the translation products were [mCherry-T2A] and GFP (8).
mCherry was amplified using the forward primer JoN1 (5′-GGATCC
ATGGTGAGCAAGGGCGAGGAGGATAA-3′; BamHI RE site under-
lined, mCherry initiation codon in bold) and the reverse primer
JoN2 (5′-TCTAGATTTGTACAATTCATCCATGCCG; XbaI RE site
underlined; mCherry stop codon removed). The PCR product was
purified, restricted with BamHI and XbaI the ligated into plasmid pJC3
(43), similarly restricted. This created a plasmid (pJN5) encoding an
[mCherry-T2A-mCherry] polyprotein. The mCherryGFP sequences
downstream of T2A were then replaced with GFP by amplifica-
tion of GFP using the forward primer JoN3 (5′-GGGCCCGATATC
GTGTCCAAAGGGGAAG AGCTGTTC-3′; ApaI and EcoRV RE sites
underlined; GFP initiation codon removed) and the reverse primer
JoN4 (5′-CTCGAGTTACTTATACAGCTCGTCCAT-3′; XhoI RE site
underlined). The PCR product was purified, restricted with ApaI and
XhoI and ligated into pJN5, similarly restricted.
Plasmid pSpNLR2A6WT-mCherry-T2A-GFP encodes a [SpNLR2A6WT-
mCherry-T2A-GFP] self-processing polyprotein (Figure 1E). Plas-
mid pJN1 was restricted with PstI, the 2463 bp fragment (encoding
ΔmCherry-T2A-GFP) isolated then ligated into plasmid pSpNLR2A6WT,
similarly restricted.
Plasmid pSpNLR2A6P3A-mCherry-T2A-GFP encodes a [SpNLR2A6P3A-
mCherry-T2A-GFP] self-processing polyprotein. The assembly of this
construct was as described for pSpNLR2A6WT above, except the insert
was ligated into plasmid pSpNLR2A6P3A restricted with PstI.
Site-directed mutagenesis
Point mutations within the SpNLR2A6WT sequence were introduced
using the QuikChange system (Agilent) as per themanufacturer’s instruc-
tions. Primers (Table 2) were obtained from IDT.
In vitro coupled transcription/translation reactions
To analyze the recoding activity of SpNLR2A sequences, plasmid
constructs were used to programme Quick TnT coupled transcrip-
tion/translation rabbit reticulocyte lysate (RRL) systems (Promega), as
described (5). These systems comprise all of the translational apparatus,
but the endogenous mRNA (primarily globin mRNA) has been degraded
Figure 7: Expression in planta. SpNLR2A6WT-mCherry (left column, Panels A, C, E, G, I) and SpNLR2A6P3A-mCherry (right column,
Panels B, D, F, H, J) expressed in plant epidermal cells (N. benthamiana). A and C) Expression of SpNLR2A6WT-mCherry and unfused
GFP from a SpNLR2A6WT-mCherry-T2A-GFP construct. Both ﬂuorescent proteins colocalize in the nucleoplasm and cytosol. B and
D) Expression of SpNLR2A6P3A-mCherry and unfused GFP from a SpNLR2A6P3A-mCherry-T2A-GFP construct. SpNLR2A6P3A-mCherry
ﬂuorescence surrounds the nucleus and is observed in ﬂuorescent halos around the cell (arrow heads in D). Weak ﬂuorescence is also
visible in the central vacuole. Left to right panels in (A and B) and (C and D) show mCherry, and mCherry/GFP merged channels,
respectively. v: central vacuole. E–H) Expression of SpNLR2A6WT-mCherry and SpNLR2A6P3A-mCherry, respectively, in transgenic
plants expressing GFP targeted to the lumen of the ER (34). SpNLR2A6WT –mCherry ﬂuorescence localizes to the nucleoplasm,
which is surrounded by the GFP-labelled nuclear envelope (E), and does not colocalize with GFP-labelled tubular cortical ER (G).
By contrast, SpNLR2A6P3A-mCherry ﬂuorescence colocalizes with both the nuclear envelope (F) and cortical ER tubules (H). (I–J)
Co-expression of SpNLR2A6WT-mCherry (I) and SpNLR2A6P3A-mCherry (J), respectively, with GFP targeted to the plasma membrane
(31). SpNLR2A6WT-mCherry localizes to the periphery of two adjacent cells whose boundaries are marked by PM-GFP (I), whereas
SpNLR2A6P3A-mCherry localizes to the cell wall space between cells (J). Images are single confocal sections except for panels G, H,
which are maximum projections of entire z-stacks. Scale bars 50 μm (Panels A–D) and 10 μm (Panels E–J).
Trafﬁc 2016 13
Roulston et al.
Table 2: Oligonucleotide primers
Primer designation SpNLR2A6 mutation Oligonucleotide primer sequence (5′ to 3′)
CR 13Lmut For L13→ V or A CTCTATCTGCTCCTGATCCTCGNNATGAGATCTGGTGACGTTGAA
CR 13Lmut Rev L13→ V or A TTCAACGTCACCAGATCTCATNNCGAGGATCAGGAGCAGATAGAG
CR 14Lmut For L14→G or D CTTCTCTATCTGCTCCTGATCGNNTTGATGAGATCTGGTGACGTT
CR 14Lmut Rev L14→G or D AACGTCACCAGATCTCATCAANNCGATCAGGAGCAGATAGAGAAG
CR 16Lmut For L16→ A,D,G or V ATTCTGTCTTCTCTATCTGCTCGNNATCCTCTTGATGAGATCTGGTG
CR 16Lmut Rev L16→ A,D,G or V CACCAGATCTCATCAAGAGGATNNCGAGCAGATAGAGAAGACAGAAT
CR 21Lmut For L21→ A,D,G or V AGAACCATGGATGGATTCTGTGNNCTCTATCTGCTCCTGATCCTC
CR 21Lmut Rev L21→ A,D,G or V GAGGATCAGGAGCAGATAGAGNNCACAGAATCCATCCATGGTTCT
CR 21Dmut For L21→ D CTCTAGAACCATGGATGGATTCTGTGATCTCTATCTGCTC
CR 21Dmut Rev L21→ D GAGCAGATAGAGATCACAGAATCCATCCATGGTTCTAGAG
CR 12 V For M12→ V GCTCCTGATCCTCTTGGTGAGATCTGGTGACGT
CR 12 V Rev M12→ V ACGTCACCAGATCTCACCAAGAGGATCAGGAGC
CR 16M For L16→M CTGTCTTCTCTATCTGCTCATGATCCTCTTGATGAGATC
CR 16M Rev L16→M GATCTCATCAAGAGGATCATGAGCAGATAGAGAAGACAG
CR 11Rm For R11→A GCTCCTGATCCTCTTGATGGCATCTGGTGACGTTGAAACC
CR 11Rm Rev R→ 11A GGTTTCAACGTCACCAGATGCCATCAAGAGGATCAGGAGC
CR 25Dm For D→ 25A CTAGCTCTAGAACCATGGCTGGATTCTGTCTTCTCTA
CR 25Dm Rev D→ 25A TAGAGAAGACAGAATCCAGCCATGGTTCTAGAGCTAG
CR CtoG For P→ 3A TGGTGACGTTGAAACCAATGCCGGGCCCAT
CR CtoG Rev P→ 3A ATGGGCCCGGCATTGGTTTCAACGTCACCA
Some oligonucleotide PCR primers were synthesized with degeneracies (‘N’) at certain positions (bold type face) to generate multiple clones each
bearing a single coding change. The sequence of each clone was determined by automated DNA sequencing. Translational recoding activity was
ablated by creating a second site mutation (P3A).
by treatment with micrococcal nuclease, which is then inactivated by
chelation of Ca++ ions by EGTA. mRNA to program the translation
system is generated by T7 RNA polymerase (a supplement to the RRL)
driving transcription from the T7 promoter within the plasmid DNA
used to program the system. No endomembranes are present unless the
reaction mixture is specifically supplemented with microsomes. Briefly,
plasmid DNA (100 ng) was used to programme the lysate master mix
(10 μL) supplemented with 35S-methionine (10 μCi). Reactions were
incubated at 30∘C (90min) before the addition of 2× SDS–PAGE loading
buffer. Translation reactions (5 μL aliquots) were then analyzed using
gradient (4–20%) SDS–PAGE gels (Expedeon). Gels were then dried
and the distribution of radiolabel determined by autoradiography.
Transient expression in HeLa cells
HeLa cells were maintained in DMEM supplemented with FCS (10%).
For microscopy, cells were transfected once they had reached 50% con-
fluency. 16 h prior to transfection cells were seeded onto 15mm sterile
glass coverslips in 6-well trays in a final volume of 2mL culturemedia. For
microscopy, cells were transfected with plasmid DNA (750 ng) and Lipo-
fectamine2000 (Invitrogen; 4 μL) then added to OptiMEM (Life Tech-
nologies) to a final volume of 200 μL. Cells were incubated at 37∘C for
a further 30 h prior to fixation. For western blotting experiments, cells
(50% confluency) were transfected with plasmid DNA (1.5 μg) and Lipo-
fectamine2000 (7 μL) then added toOptiMEM to a final volume of 400 μL,
cultured at 37∘C for a further 30 h prior to harvesting. For brefeldin A
(BFA; Sigma-Aldrich) treatment, BFA was added to a final concentration
of 15 μg/mL 45min prior to fixing.
HeLa cell microscopy
Cells were fixed using the protocol as described (43). Briefly, the coverslips
were washed 2x with PBS, fixed for 10min in ice-cold methanol and
subsequently washed 2× with deionized water, before mounting on glass
microscope slides. Images were obtained using a Deltavision microscope
and images analyzed using the RESOLVE 3D software package.
Cell extracts
Extracts were prepared using the protocol as described (43). Briefly, 30 h
post-transfection media was removed and cells washed 2× with 1mL of
PBS, harvested in 1mL PBS pelleted by centrifugation (100g, 5min). The
cell pellet was resuspended in 70 μL RIPA buffer (NaCl, 150mM; Tris
pH 7.4, 10mM; Triton X-100, 1%, Na deoxycholate 1% and SDS, 0.1%).
EDTA-free protease inhibitor cocktail was added freshly (1:20 v/v), the
cells incubated on ice for 30min and centrifuged at 3540g (4∘C, 20min).
The cellular debris pellet was discarded and the supernatant analyzed by
12% SDS–PAGE.
Western blotting
Proteins were transferred to a nitrocellulose membrane using an iBlot
system as per the manufacturer’s instructions (Life Technologies).
Membranes were then blocked in PBST with non-fat dried milk (5%)
for 1 h prior to probing with anti-mCherry, anti-GFP or anti-β-tubulin
primary antibodies overnight. Post incubation, membranes were washed
3x in PBST. Bound antibodies were detected using HRP-secondary
antibody (Dako) in PBST with milk (1 h). Membranes were then washed
3× in PBST, rinsed in deionized water and finally subjected to enhanced
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chemi-luminescence by incubation in freshly-prepared visualization
solution (2min). The membrane was exposed to autoradiography film
(Kodak) for 3 to 45 seconds, as appropriate.
Quantitative western blotting
Cell extracts were prepared as described above. Cell culture media were
clarified by centrifugation (4∘C, 500× g, 10min), then four volumes of
acetone (pre-chilled to −20∘C) were added, vortexed for 20 seconds
and incubated at −20∘C for I h. The protein suspension was pelleted
(4∘C, 15 000× g, 10min), the supernatant carefully removed and the
pellet air-dried for 30min prior to being dissolved in SDS gel loading
buffer. Equal proportions of proteins derived from either the total cell
extract or cell medium were subjected to SDS (10%) gel electrophore-
sis then transferred to Immobilon-FL membranes using the wet trans-
fer method (Merck-Millipore). Membranes were blocked using Li-Cor
blocking buffer (PBS), probed using anti-mCherry or anti-β-tubulin pri-
mary antibodies as described above, then with Li-cor IRdye 800CW
and IRdye 680RD secondary antibodies. Membranes were then ana-
lyzed using a Li-Cor Odyssey scanner and the images analyzed using
Image Studio Lite. For either pSpNLR2A6WT-mCherry-T2A-GFP or
pSpNLR2A6P3A-mCherry-T2A-GFP plasmid transfected cells, the pro-
portion of mCherryFP that was either cell-associated or in the culture
mediawas calculated by dividing the intensity of each fluorescent intensity
signal (from the secondary antibody) by the combined total.
Mass spectrometry
The region of a Coomassie-blue stained SDS gel corresponding to
25–30 kDa was excised and cut into 1mm cubes which were then
subjected to in-gel digestion using a ProGest Investigator in-gel digestion
robot (Genomic Solutions) using standard protocols (44). Briefly, the
gel cubes were de-stained by washing with acetonitrile and subjected to
reduction and alkylation before digestion with trypsin at 37∘C. Peptides
were extracted with 10% formic acid and concentrated down to 20 μL
using a SpeedVac (ThermoSavant). Peptides were then separated using
a nanoLC Ultra 2D plus loading pump and nanoLC AS-2 autosampler
equipped with a nanoflex cHiPLC chip based chromatography system
(Eskigent), using a ChromXP C18-CL trap and column (Eskigent).
Peptides were eluted with a gradient of increasing acetonitrile, containing
0.1% formic acid (5–25% acetonitrile in 75min, 25–80% in a further
15min). The eluent was sprayed into a TripleTOF 5600 electrospray
tandem mass spectrometer (ABSciex) and analyzed in Information
Dependent Acquisition (IDA) mode, performing 250milliseconds of MS
followed by 100millisecods MSMS analyses on the 20 most intense peaks
determined by MS. The MS/MS data file generated was analyzed using
the ProteinPilot 4.1 Paragon algorithm (ABSciex) against an internal
protein database to which the [SpNLR2A6WT-mCherry-T2A] peptide
sequence had been added, with trypsin as the cleavage enzyme and car-
bamidomethyl modification of cysteines. The Mascot algorithm (Matrix
Science) was set for trypsin cleavage at only one end of the peptide
(semi-trypsin), carbamidomethyl as a fixed modification of cysteines and
methionine oxidation plus deamidation of glutamines and asparagines as
variable modifications.
Plant expression vectors
SpNLR2A6WT-mCherry-T2A-GFP and SpNLR2A6P3A-mCherry-T2A-
GFP reporter constructs were amplified from pSpNLR2A6WT-mCherry-
T2A-GFP and pSpNLR2A6P3A-mCherry-T2A-GFP, respectively, using
the forward primer 5′-ATAGCGTTAATTAAAGCTCTAGAACC
ATGGATGGATTCTG-3′ and reverse primer 5′-ATTAATGCGGCCGC
CTCGAGTTACTTATACAG-3′ (PacI / NotI restriction sites under-
lined; translation start/stop codons in bold typeface). PCR products
were digested with PacI and NotI and ligated into the TMV-based
over-expression vector pTRBO, similarly restricted (30). For colo-
calization with GFP organelle markers, SpNLR2A6WT-mCherry
and SpNLR2A6P3A-mCherry were excized as XhoI-NotI fragments
from plasmids pSpNLR2A6WT and pSpNLR2A6P3A, respec-
tively, blunt-ended with T4 DNA polymerase and ligated into
XmnI/EcoRV-linearized pENTR1A (Invitrogen).The resulting Gateway®
entry vectors were recombined with the plant expression vector
pGWB402Ω (45).
Plant inoculations
pTRBO.SpNLR2A6WT-mCherry-T2A-GFP and pTRBO.SpNLR2A6P3A-
mCherry-T2A-GFP were each electroporated into Agrobacterium tume-
faciens (strain AGL1) cells. Single agrobacteria colonies were grown in
liquid culture at 28∘C for 2 days, pelleted and resuspended in infiltration
medium (10mMMES; 10mMMgCl2; 15 μM acetosyringone) to an optical
density of 0.001 at 600 nm.The agrobacterium suspension was infiltrated
into small incisions on the abaxial side of N. benthamiana leaves using a
syringe without a needle. pGWB402Ω-based expression vectors and the
GFP-LTI plasma membrane marker (31) were similarly introduced by
agrobacteria infiltration, except that the suspension had an optical density
of 0.25 at 600 nm. For colocalization with the ER, pGWB402Ω constructs
were agroinfiltrated into transgenic N. benthamiana plants expressing
ER-targeted GFP (32). Plants were kept at 25∘C, 16 h light/8 h dark and
imaged at 4 days post-infiltration.
Plant cell imaging and image analysis
Infiltrated leaves were detached and adhered onto microscope slides
with the abaxial side facing up using double-sided sticky tape. Leaves
were imaged on an upright SP2 confocal laser scanning microscope
(Leica) equipped with a 40× water dipping lens. GFP was excited at
488 nm and detected at 495–525 nm, mCherry was excited at 594 nm
and detected at 600–630 nm. Images were exported into IMAGEJ software
for ratiometric measurements and into ADOBE PHOTOSHOP for assembly
of figures.
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